![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Company type
Biopharmaceutical company focused on bispecific antibodies.Funding rounds
Series A USD 25,000,000
USD 25,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Oriza Seed Venture Capital | Led the round. | ||
|
|
3E Bioventures Capital | |||
|
Decheng Capital (德诚资本) | |||
|
|
Trend Investments Group LLC |
Investment activity status
Active investor